Stainless steel installations are often cost-prohibitive and time-consuming. In contrast, adoption of single-use or hybrid systems represents a faster, more flexible, and less capital-intensive route. When selecting a single-use bioreactor platform, key considerations include scalability and quality control:
Webinars:
Implementation of Single-use Upstream Technologies in Fed-batch Operations
Review of a Supplier's Quality Control While Manufacturing Single-use Systems
Overcoming Quality and Regulatory Challenges of Implementing Single-use Pharmaceutical Manufacturing
Article: Managing Quality in Single-use Systems
Webinar: A Scale-up to 2000L, Blindfolded!
Article: Demonstrating Process Scalability with Robust and Turnkey Platforms
Article: Mobius® Single-use Bioreactors: Platform Scalability
Webinars:
Tech Transfer and Scale-up – Tips and Tricks from a Biodevelopment Center
Managing Process Scale-up and Tech Transfer
Converting from pilot to process scale and transferring technology requires precise and seamless organization, communication, and documentation. A well-developed technology transfer package:
Development begins by selecting single-cell clones that can produce the biologic of interest, then screening for clones that are stable, productive, and scalable
Achieving consistent cell culture performance requires careful screening, selection, and optimization of media formulations and feed
Monoclonal antibody manufacturing is a highly templated approach used to produce mAb-based immunotherapies. Robust, scalable process solutions are required at every step to ensure high therapeutic concentration and process safety, while meeting speed-to-market and cost containment concerns.
To continue reading please sign in or create an account.
Don't Have An Account?